PURPOSE:Neopterin is a marker of activation of the T-lymphocyte/monocyte axis. We measured serum neopterin concentration to investigate whether serum neopterin levels are increased in children with Graves' disease and whether serum neopterin measurement can be used as a marker of disease activity in Graves disease. METHODS:Twenty children with Graves' disease(3 boys and 17 girls) and 15 healthy children(7 boys and 8 girls) are enrolled in this study. Serum neopterin concentrations are measured by radioimmunoassay. RESULTS:Neopterin concentration in children with Graves' disease(1.59+/-1.25ng/ml) is not higher than that of healthy children(1.51+/-0.73ng/ml). Neopterin concentration is not influenced by thyroid function and remission state. CONCLUSION: Serum neopterin level in children with Graves' disease can not be used as a marker of activity.
Axis, Cervical Vertebra ; Child* ; Graves Disease* ; Humans ; Neopterin* ; Radioimmunoassay ; Thyroid Gland

No abstract available.
Kinetics* ; Wrist*

No abstract available.
Lymphadenitis*

PURPOSE: The purpose of this study was to correlate birth weight, skinfold thickness, gestational age, BMI and ponderal index of neonates and maternal status with cord serum leptin concentration. METHODS: Sixty newborns were enrolled in this study. Standard growth curves were used to categorize infants as appropriate(AGA), large(LGA), or small for gestational age(SGA). Gestational age, birth weight, length, skinfold thickness, and placental weight were measured. Maternal age, weight, and height were measured. Cord blood and maternal venous blood samples were collected, and serum was separated and stored at -20degrees C. Leptin was measured by radioimmunoassay. RESULTS: Mean leptin concentration in cord blood was 4.38+/-2.65ng/ml and closely related to size and adiposity at birth, but not to gestational age. Cord blood leptin level was significantly lower in SGA infants(1.64+/-0.58ng/ml) and higher in LGA infants(5.53+/-2.64ng/ml) than in AGA infants (4.99+/-2.37ng/ml)(P<0.05). Mean leptin concentration in maternal blood(13.01+/-8.28ng/ml) was significantly higher than in cord blood(P<0.001), and maternal obesity and serum leptin concentrations did not correlate with cord blood leptin concentrations. No gender differences were found in cord blood leptin. CONCLUSION: The leptin level of cord blood is highly correlated to the birth weight and the size of adipose tissue. Leptin may be responsible for the regulation of body mass of human neonates and can be used as a marker of fetal growth.
Adipose Tissue ; Adiposity ; Birth Weight* ; Fetal Blood* ; Fetal Development ; Gestational Age ; Humans ; Infant ; Infant, Newborn ; Leptin* ; Maternal Age ; Obesity ; Parturition* ; Radioimmunoassay ; Skinfold Thickness

Foreign body aspiration (especially peanut) is the leading cause of accidental death in children under 1 year of age and most cases of serious aspiration occur between the age of 1 and 3. We report a case of severe pulmonary complication and adult respiratory distress syndrome (ARDS) secondary to peanut aspiration in 15 month old male in spite of all removal (9 pieces) by ventilating bronchoscope. Chest X-ray showed pulmonary interstitial emphysema, marked subcutaneous emphysema, pneumothorax and autopsy findings showed interstitial inflammatory cell infiltration with destruction of acinar septal architecture and formation of hyaline membranes. Chest X-ray and pathologic findings are compatible with the late ARDS. A brief review of related literature was made.
Autopsy ; Bronchoscopes ; Child ; Emphysema ; Foreign Bodies ; Humans ; Hyalin ; Infant* ; Male* ; Membranes ; Pneumothorax ; Respiratory Distress Syndrome, Adult ; Subcutaneous Emphysema ; Thorax

INTRODUCTION: There are three anatomic findings that correlate with a patient risk for developing anterior acromial impingement : acromial shape, anterior downsloping of the acromion. To analyze the effect of anterior and lateral downslopings and subacromial interval to the impingement syndrome retrospectively, the authors reviewed 32 patients who performed MRI of the shoulder joint in the Dankook university hoipital. MATERIALS AND METHODS: Eighteen males & fourteen females were reviewed and the average age was 46.6 years old. There were 23 cases of impingement syndrome and 9 cases of control group. The authors analyzed oblique coronal images and oblique sagittal images in shoulder MRI.
Acromion ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Retrospective Studies ; Shoulder Impingement Syndrome ; Shoulder Joint ; Shoulder

Expression of MHC class II molecule by retinal pigment epithelial cells and the interaction of the cell with extracellular matrix molecules involve in the pathogenesis of proliferative vitreoretinopathy and chorioretinitis. In this study interferon-gammainduced the expression of MHC class II molecules on RPEJ cells. Extracellular matrix molecules increased the interferon-gamma-i n d u c e d expression of MHC class II molecules. TGF-beta2 inhibited the interferon-gammainduced expression of MHC class II molecules. However, there was no significant effect on such inhibitory function according to the types of extracellular matrix molecules. Blocking the autocrine effect of TGF-beta2 by the specific antisense oligonucleotides decreased its inhibitory function. PLC-gamma1-specific antisense oligonucleotide inhibited the effect of TGF-beta2, which suggests that PLC-gamma1 involves in the signal transduction of TGF-beta2 on the expression of MHC class II molecules. In conclusion, the present study provides further understandings to the previous knowledge of pathogenesis of immunologic retinal disorders.
Chorioretinitis ; Epithelial Cells ; Extracellular Matrix ; Interferon-gamma ; Oligonucleotides, Antisense ; Retinal Pigment Epithelium* ; Retinaldehyde* ; Signal Transduction ; Transforming Growth Factor beta2 ; Vitreoretinopathy, Proliferative

PURPOSE: In some girls with central precocious puberty (CPP), growth velocity (GV) decreases below the age-appropriate normal range during gonadotropin-releasing hormone agonist (GnRHa) treatment. The purpose of this study was to investigate clinical and laboratory factors related to changes in GV during GnRHa treatment in girls with CPP. METHODS: We analyzed clinical and laboratory data of 49 girls (aged 7.8+/-0.5 years) with idiopathic CPP who were treated with GnRHa. GV, height standard deviation score (SDS), hormonal parameters, pubertal stage, chronological age and bone age (BA) were evaluated. RESULTS: GV during the first year of GnRHa treatment was 5.9+/-1.0 cm/yr and decreased significantly to 5.4+/-1.1 cm/yr during the second year of treatment (P = 0.005). GV during the third year (5.0+/-1.0 cm/yr) was not different from GV during the second year. During the second year of treatment, 8.2% and 36.7% of the girls had a GV < 4 cm/yr and < 5 cm/yr, respectively. Girls with relatively low GV during the second year of treatment (< 5 cm/yr) showed higher risk of advanced BA (> or = 11 yr) at 1 year (55.6% vs. 19.4%; odds ratio [OR], 5.2; P = 0.022). In multivariate logistic regression analysis, more advanced BA at 1 year (OR, 6.1; 95% confidence interval [CI], 1.57-23.87) and lower height SDS for BA at 1 year (OR, 0.24; 95% CI, 0.06-0.94) were associated with relatively decreased GV (< 5 cm/yr) during the second year of GnRHa treatment. CONCLUSION: GV during and after the second year of GnRHa treatment in girls with idiopathic CPP remains within the normal prepubertal range, and relatively low GV during GnRHa treatment is associated with more advanced BA and lower height SDS for BA.
Gonadotropin-Releasing Hormone ; Logistic Models ; Odds Ratio ; Piperazines ; Puberty, Precocious ; Reference Values

PURPOSE: In some girls with central precocious puberty (CPP), growth velocity (GV) decreases below the age-appropriate normal range during gonadotropin-releasing hormone agonist (GnRHa) treatment. The purpose of this study was to investigate clinical and laboratory factors related to changes in GV during GnRHa treatment in girls with CPP. METHODS: We analyzed clinical and laboratory data of 49 girls (aged 7.8+/-0.5 years) with idiopathic CPP who were treated with GnRHa. GV, height standard deviation score (SDS), hormonal parameters, pubertal stage, chronological age and bone age (BA) were evaluated. RESULTS: GV during the first year of GnRHa treatment was 5.9+/-1.0 cm/yr and decreased significantly to 5.4+/-1.1 cm/yr during the second year of treatment (P = 0.005). GV during the third year (5.0+/-1.0 cm/yr) was not different from GV during the second year. During the second year of treatment, 8.2% and 36.7% of the girls had a GV < 4 cm/yr and < 5 cm/yr, respectively. Girls with relatively low GV during the second year of treatment (< 5 cm/yr) showed higher risk of advanced BA (> or = 11 yr) at 1 year (55.6% vs. 19.4%; odds ratio [OR], 5.2; P = 0.022). In multivariate logistic regression analysis, more advanced BA at 1 year (OR, 6.1; 95% confidence interval [CI], 1.57-23.87) and lower height SDS for BA at 1 year (OR, 0.24; 95% CI, 0.06-0.94) were associated with relatively decreased GV (< 5 cm/yr) during the second year of GnRHa treatment. CONCLUSION: GV during and after the second year of GnRHa treatment in girls with idiopathic CPP remains within the normal prepubertal range, and relatively low GV during GnRHa treatment is associated with more advanced BA and lower height SDS for BA.
Gonadotropin-Releasing Hormone ; Logistic Models ; Odds Ratio ; Piperazines ; Puberty, Precocious ; Reference Values

This article provides an overview of the developmental history and rationale of medical ethics to establish the code of ethics and professional conduct of the Korean Academy of Child and Adolescent Psychiatry (KACAP). Most medical professional organizations have their own codes of ethics and conduct because they have continuous responsibility to regulate professional activities and conducts for their members. The Ethics and Award Committee of the KACAP appointed a Task-Force to establish the code of ethics and conduct in 2012. Because bioethics has become global, the Ethics Task Force examined global standards. Global standards in medical ethics and professional conduct adopted by the World Medical Association and the World Psychiatric Association have provided the basic framework for our KACAP's code of ethics and professional conduct. The Code of Ethics of the Americal Academy of Child and Adolescent Psychiatry has provided us additional specific clarifications required for child and adolescent patients. The code of ethics and professional conduct of the KACAP will be helpful to us in ethical clinical practice and will ensure our competence in recognizing ethical violations.
Adolescent ; Adolescent Psychiatry* ; Adolescent* ; Advisory Committees ; Awards and Prizes ; Bioethics ; Child* ; Codes of Ethics ; Ethics ; Ethics, Medical* ; Humans ; Mental Competency ; Societies